COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATION AND PAIN
M Kandula - US Patent App. 14/647,130, 2018
… The pharmaceutical composition of claim 23, wherein said inflammation
mediated pain is caused by oral mucositis, oral ulceration, oral inflammation,
oral infection, oral wounds, dental surgery, post-tosillectomy …
mediated pain is caused by oral mucositis, oral ulceration, oral inflammation,
oral infection, oral wounds, dental surgery, post-tosillectomy …
[PDF] Technical Innovations & Patient Support in Radiation Oncology
AM Podlesko, N Ramacciati, S Panzolini, S Saldi… - environment, 2018
… RT was associated with weekly cisplatinum-based CT (30 mg/m2). In the
3rd week of RT, after receiving 24.2Gy the patient developed Grade 3 oral
mucositis, glossitis, edema and pain leading to weight loss and depression …
3rd week of RT, after receiving 24.2Gy the patient developed Grade 3 oral
mucositis, glossitis, edema and pain leading to weight loss and depression …
Compounds
J Adams, Y Lian - US Patent 9,994,607, 2018
A compound of Formula (I) <p><chemistry id="CHEM-US-00001" num="00001"><
img id="EMI-C00001" he="54.02mm" wi="75.86mm" file="US09994607-20180612-
C00001.TIF" alt="embedded image" img-content="chem" img-.
img id="EMI-C00001" he="54.02mm" wi="75.86mm" file="US09994607-20180612-
C00001.TIF" alt="embedded image" img-content="chem" img-.
Αυτή η ειδοποίηση αποστέλλεται από τον Μελετητή Google. Ο Μελετητής Google είναι μια υπηρεσία που παρέχεται από την Google.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου